Advance your academic career, collaborate globally, and expand your network— join now !

Simone Dalm

Ms. Simone Dalm

Department of Radiology & Nuclear Medicine, Erasmus University Medical Cente...

Share Link

Share

Information

Simone Dalm is currently an Assistant Professor and Principal Investigator of Radiotracer Interactions at the Department of Radiology & Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. She obtained a BSc in Biomedical Science and a MSc in Oncology at VU University Amsterdam. She completed her PhD studies at the Erasmus MC in Rotterdam in 2016. She then continued as a postdoctoral fellow at the department and developed her research line and group (The Radiotracer Interactions Group) for which she received multiple personal grants (KWF Young Investigator’s Grant and ZonMw Veni). She obtained the ZonMw Veni (2019) and the KWF Young Investigator's Grant/Bas Mulder Award (2018). Her research interests are breast cancer; prostate cancer; nuclear imaging and therapy; targeted therapy; molecular and cell biology; and cancer diagnostics.

Research Keywords & Expertise

Breast Cancer
Prostate Cancer
targeted therapy
Molecular and Cell Bio...
Cancer diagnostics

Short Biography

Simone Dalm is currently an Assistant Professor and Principal Investigator of Radiotracer Interactions at the Department of Radiology & Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. She obtained a BSc in Biomedical Science and a MSc in Oncology at VU University Amsterdam. She completed her PhD studies at the Erasmus MC in Rotterdam in 2016. She then continued as a postdoctoral fellow at the department and developed her research line and group (The Radiotracer Interactions Group) for which she received multiple personal grants (KWF Young Investigator’s Grant and ZonMw Veni). She obtained the ZonMw Veni (2019) and the KWF Young Investigator's Grant/Bas Mulder Award (2018). Her research interests are breast cancer; prostate cancer; nuclear imaging and therapy; targeted therapy; molecular and cell biology; and cancer diagnostics.